Notice of Annual Results

Cathay International Holdings Limited

Notice of Annual Results 2013

Hong Kong, 14 March 2014 - Cathay International Holdings Limited ("Cathay" or "the Company") (LSE: CTI.L), an investment holding company and leading investor in the growing healthcare sector in the People's Republic of China, today announces the Company will issue its Annual Results for the year ended 31 December 2013 on Friday, 28 March 2014.

-Ends-

For further enquiries, please contact:

About Cathay

Cathay International Holdings Limited (LSE: CTI.L), focused on the People's Republic of China ("PRC"), is an investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China ("PRC"). The Cathay group employs more than 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen.

Cathay aims to identify investment opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. Cathay has demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: the Lansen group, China's leading specialty pharmaceutical company focused on rheumatology and dermatology, the Haotian Haizi group, a company engaged in the manufacture, marketing and sale of inositol and DCP, and the Haotian Yangling group, a company engaged in the extract and trading of key active ingredients for healthcare products. To complement its healthcare portfolio, Cathay has a research and product development business focused on bringing new products to the growing Chinese market.

Cathay also has a private equity investment arm focused on minority investment opportunities and a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk